Canine lymphoma.
This article presents an overview of the literature regarding canine malignant lymphoma. It includes a discussion of etiology, classification, systemic manifestations of disease, therapy, and supportive care for patient management.
Madewell
B R
BR
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001707:Biopsy, Needle / Q000662:veterinary; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D004283:Dog Diseases / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D004285:Dogs; D004338:Drug Combinations / Q000008:administration & dosage; D008198:Lymph Nodes / Q000473:pathology; D008223:Lymphoma / Q000145:classification / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology / Q000628:therapy / Q000662:veterinary*; D010166:Palliative Care / Q000662:veterinary; D011241:Prednisone / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
D004338:Drug Combinations; D003561:Cytarabine; D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone